Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study..

Thordardottir M, Lindqvist EK, Lund SH, Costello R, Burton D, Korde N, Mailankody S, Eiriksdottir G, Launer LJ, Gudnason V, Harris TB, Landgren O, Kristinsson SY. Blood Adv. 2017;1(24):2186-2192. PMID:29296866